Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study.

Kuan-Chieh LeeJur-Shan ChengMing-Ling ChangRong-Nan ChienYun-Fan Liaw

Published in: Hepatology international (2022)

ETV and TDF had comparable efficacy in the short- and long-term liver-related outcomes of decompensated CHB patients, and baseline liver reserve was associated with the outcomes.

Keyphrases

ejection fraction
heart failure
hepatitis b virus
prognostic factors
type diabetes
metabolic syndrome
skeletal muscle
adipose tissue
patient reported outcomes
antiretroviral therapy
peritoneal dialysis
weight loss
patient reported